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Abstract
Background: Pigs play a key epidemiologic role in the ecology of influenza A viruses (IAVs) emerging from animal hosts and
transmitted to humans. Between 2008 and 2010, we investigated the health risk of occupational exposure to swine
influenza viruses (SIVs) in Italy, during the emergence and spread of the 2009 H1N1 pandemic (H1N1pdm) virus.
Methodology/Principal Findings: Serum samples from 123 swine workers (SWs) and 379 control subjects (Cs), not exposed
to pig herds, were tested by haemagglutination inhibition (HI) assay against selected SIVs belonging to H1N1 (swH1N1),
H1N2 (swH1N2) and H3N2 (swH3N2) subtypes circulating in the study area. Potential cross-reactivity between swine and
human IAVs was evaluated by testing sera against recent, pandemic and seasonal, human influenza viruses (H1N1 and H3N2
antigenic subtypes). Samples tested against swH1N1 and H1N1pdm viruses were categorized into sera collected before
(n. 84 SWs; n. 234 Cs) and after (n. 39 SWs; n. 145 Cs) the pandemic peak. HI-antibody titers $10 were considered positive.
In both pre-pandemic and post-pandemic peak subperiods, SWs showed significantly higher swH1N1 seroprevalences
when compared with Cs (52.4% vs. 4.7% and 59% vs. 9.7%, respectively). Comparable HI results were obtained against
H1N1pdm antigen (58.3% vs. 7.7% and 59% vs. 31.7%, respectively). No differences were found between HI seroreactivity
detected in SWs and Cs against swH1N2 (33.3% vs. 40.4%) and swH3N2 (51.2 vs. 55.4%) viruses. These findings indicate the
occurrence of swH1N1 transmission from pigs to Italian SWs.
Conclusion/Significance: A significant increase of H1N1pdm seroprevalences occurred in the post-pandemic peak
subperiod in the Cs (p,0.001) whereas SWs showed no differences between the two subperiods, suggesting a possible
occurrence of cross-protective immunity related to previous swH1N1 infections. These data underline the importance of risk
assessment and occupational health surveillance activities aimed at early detection and control of SIVs with pandemic
potential in humans.
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Introduction
Viral exchange between human and animal populations is
a crucial element in the origin of influenza pandemic strains. As in
the pandemics of 1918, 1957 and 1968, caused by H1N1, H2N2
and H3N2 influenza A virus (IAV) antigenic subtypes, respective-
ly, in the early third millennium the animal reservoir has played
a key role in the origin and emergence of the 2009 H1N1
pandemic (H1N1pdm) virus, turned out to be a quadruple
reassortant containing IAV genes from pigs, birds and humans
[1]. Among animal species, pigs play an important role in
influenza interspecies transmission, associated with viral gene
reassortment, possibly occurring in pig tracheal epithelial cells
during simultaneous infection of both avian and mammalian IAVs
[2]. In addition, it is well known the ability of pigs to serve as
intermediate hosts for the adaptation of avian viruses to mammals,
including humans [3].
Swine influenza monitoring programs have been in place in
Italy since 1990 s [4] and currently three prevalent antigenic
subtypes, belonging to the Eurasian avian-like H1N1 and human-
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like H3N2 and H1N2 lineages, are circulating in Italian pigs [5–6].
The predominant swine H1N1 viruses have an entirely avian
genome, and emerged in European pigs in 1979 [7]. The H3N2
swine viruses present in Europe since 1984 are human-avian
reassortants, with avian-derived internal genes and haemaggluti-
nin (HA) and neuraminidase (NA) genes of human origin [8]. The
H1N2 swine influenza viruses (SIVs) currently circulating in
Europe have the HA and NA genes of human origin and derive
from viruses that were first introduced in Great Britain in 1994, as
a result of multiple reassortment events involving initially human
H1N1 and H3N2 and later avian-like swine H1N1 viruses [9];
H1N2 SIVs circulating in Italy have acquired, by a further
reassortment event, a different NA deriving from recent human
H3N2 viruses [6].
Since 1958, occasional cases of swine influenza infections have
been reported in subjects with symptomatic infection, with the first
SIV isolation in humans dated back to 1974 [10]. Seroepidemio-
logical surveys were also carried out on swine-exposed workers to
identify seroprevalences of antibodies against SIVs and to evaluate
the public and occupational health impact. In particular, indirect
evidence of SIV transmission to humans was found in America
[11–17], Europe [18–20] and Asia [21].
The present study is part of a wide occupational medicine
survey conducted from 2008 to 2010 in a densely pig-populated
area of Northern Italy, and aimed to biologic risk assessment and
to occupational health and safety appraisals, by means of worksites
inspections, administration of specific questionnaires and seropre-
valence surveys.
To assess the health risk of occupational exposure to swine
influenza, sera from swine workers and controls were tested for the
detection of antibodies against H1N1, H3N2 and H1N2 SIVs,
circulating in the farms under study and representative of the
above mentioned lineages [22–23]. To evaluate the antigenic
cross-reactivity between HA proteins of SIVs and co-circulating
human influenza A viruses, serum samples were also tested against
seasonal H1N1 and H3N2 subtypes, and the H1N1pdm virus,
which arose and spread in the human population [24] during the
present study. Analysis of H1N1pdm antibody seroprevalences
before and after the pandemic peak in Italy was also tailored to
testing the hypothesis of the occurrence of cross-reactive immunity
to the H1N1pdm virus in swine-exposed workers.
Our findings provide serologic evidence of swH1N1 trans-
mission from pigs to Italian swine workers, and suggest that anti-
swH1N1 antibodies have induced cross-protective immunity
against the H1N1pdm virus.
Materials and Methods
Study Population
Between 15 December 2008 and 3 October 2010, sera were
collected from 123 swine workers (SWs), operating in 23 farms of
Lombardia Region, Northern Italy, that accounts for 51% of
Italian pig population [25], and from 379 control subjects (Cs)
employees in public and private companies of the same study area.
SWs recruited represented 39.3% of individuals employed in the
23 farms under study. The time range of sera collection included
the onset of the 2009 H1N1 pandemic, reaching its peak in Italy in
the week 45 (2–8 November 2009) [26].
Socio-demographic and personal data, occupational history,
history of influenza vaccination, individual and environmental
biological risk factors, including exposure to pigs, were collected by
an occupational health trained physician, through direct interview,
by means of standardized questionnaires and workplace inspec-
tions. According to the Italian law, no ethical approval was
needed, because the study was conducted as part of the
occupational health surveillance program. A written informed
consent was obtained from all participants.
Laboratory Procedures
Antigenic characterisation of viruses. Swine influenza
antigens were preliminarily selected among isolates from pigs
reared in the 23 farms under study. Eighteen SIVs, including one
H1N2, seven H1N1, ten H3N2 virus strains associated to
outbreaks of acute respiratory disease occurring from 2006 to
2008, were characterized by cross-haemagglutination inhibition
(cross-HI) test using three selected reference hyperimmune chicken
sera, raised against co-circulating H1N1, H1N2, H3N2 antigenic
subtypes of SIVs. Serologic cross-reactivity between swine and
recent human influenza viral strains (seasonal H1N1 and H3N2,
H1N1pdm) was assessed through cross-testing of reference
antisera, according to current scientific findings [13,15,19–20].
Analysis of human sera. Receptor destroying enzyme
(RDE) (Sigma, St. Louis, MO) treated sera were examined by
a standardized haemagglutination inhibition (HI) method [27]
using four haemagglutinating units (HAUs) of virus and 0.5%
turkey red blood cells. HI titers were expressed as the reciprocal of
the highest serum dilution inhibiting four HAUs of antigen and
sera with HI titers $10 were considered positive for influenza
antibodies.
Collected sera were assayed by the HI test against six strains of
recently circulating swine and human influenza A viruses: A/Sw/
Italy/44795/08 (swH1N1), A/Sw/Italy/114347–1/06 (swH1N2),
A/Sw/Italy/32242/06 (swH3N2), A/Brisbane/59/07 (huH1N1),
A/Uruguay/716/07 (A/Brisbane/10/07-like) (huH3N2), A/Ca-
lifornia/7/2009 (H1N1pdm). SIV strains, grown in embryonated
chicken eggs, were representative of the Eurasian avian-like H1N1
and human-like H1N2 and H3N2 lineages, as shown by previous
phylogenetic analyses of Italian isolates [22–23]. Vaccinal subunits
were chosen as human influenza antigens since preliminary HI
assays of human sera tested against both whole and purified
antigens showed higher sensitivity associated with the purified ones
(data not shown). Human influenza antigens were used to
evaluate: i) the HI serologic cross-reactivity between SIVs
belonging to human-like H1N2 and H3N2 lineages, and co-
circulating seasonal strains (H1N1 and H3N2 subtypes, respec-
tively); ii) the HI serologic cross-reactivity between Eurasian avian-
like H1N1 swine influenza viruses and the H1N1pdm virus.
Statistical Analysis
HI antibody titers and selected data from questionnaire (age,
sex, vaccination history, exposure to pigs) of 502 participants were
combined into a database, using SPSS v. 19 statistical software.
To assess the zoonotic potential of H1N1, H1N2 and H3N2
SIV infections, seroprevalence rates (SPRs) detected in SWs and
Cs were compared. Levels of seropositivity to swH1N1 and
H1N1pdm viruses detected in SWs and Cs before and after the
pandemic peak were also compared, referring to conventional cut-
off date of 1 November 2009, that was chosen taking into account
the Italian epidemiological context [26]. HI SPRs were compared
referring to three cutoff levels, ranging from 10 (minimum level of
detection) to 40 (protective antibody titer) [28].
In geometric mean titer calculation, a titer less than 10 was
assigned a value of 5.
Pearson’s chi-square or Fisher’s exact tests and bivariate logistic
regression analysis were used as appropriate. When relevant, 95%
confidence intervals (CI) were computed. P values ,0.05 were
considered as statistically significant.
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Results
Study Population
Study and control subjects were categorized by age, sex and
vaccination history as shown in Table 1. Mean age of the 123 SWs
was 45.05 years (range 17–75 years), and 95.1% were male. Mean
age of the Cs was 39.75 (range 20–61), and 76.5% were male. The
Chi-square test showed significant differences in age and sex
distribution. Cs showed a greater proportion of females, more
subjects under 40 years of age and fewer in the .50 years age
class. Low vaccination coverage was detected both in the control
population and in risk group, without significant differences.
Antigenic Characterisation of Viruses
Serologic characterization by cross-HI test has shown a high
degree of antigenic homology within all the examined H1N1
(Table 2) and H3N2 (Table 3) SIVs. A/Sw/Italy/44795/08
(swH1N1), A/Sw/Italy/114347–1/06 (swH1N2), A/Sw/Italy/
32242/06 (swH3N2), were finally selected.
Swine H1N1 antiserum showed cross-reactivity against human
H1N1pdm virus, with HI titer of 160; comparable results were
also obtained by testing human H1N1pdm antiserum against
swH1N1 viruses. Low cross-reaction was detected with swine
H1N2 and swine H1N1 antisera against human H1N1 seasonal
virus (HI titers of 10 and 20 respectively), whereas antiserum
against human H1N1 seasonal virus did not cross-react with swine
H1N1 and H1N2 viruses under study (Table 2).
Finally, no cross-reactivity was detected between recent swine
and human H3N2 influenza viruses (Table 3).
Serological Results of the Whole Study Period
To investigate the health risk of occupational exposure to SIVs,
HI antibody reactivities in sera of SWs and Cs were compared as
shown in Table 4.
Taking into account the antigenic cross-reactivity (Table 2) and
the HA genetic origin of viral strains [29], results of paired swine
and human viruses were analyzed as follows:
Swine avian-like H1N1 and H1N1pdm influenza
viruses. Comparison between swH1N1seroprevalences showed
significant higher values in SWs compared with Cs at cutoff titer of
$10, $20, $40. Comparable seroprevalence results were
obtained using the H1N1pdm antigen in HI assay, showing that
antibody responses against swH1N1 virus and H1N1pdm virus
correlated with each other as detected by cross HI-test (Table 2).
Bivariate logistic regressions showed significant difference
between HI seroprevalence rates (SPRs) detected in SWs and
Cs, at all cut-off levels, for swH1N1 and H1N1pdm viruses, with
evidence of an age effect. Adjusted odds ratios have been
calculated to take into account the unbalanced age distribution
between swine workers and controls (age strata as #40, 41–50 and
.50 were considered).
Swine human-like H1N2 and seasonal H1N1 influenza
viruses. Bivariate logistic regressions showed no differences
between HI seroreactivity detected in SWs and Cs against the
swH1N2 virus, at each cutoff value. SPRs for huH1N1 virus were
higher in Cs than in SWs, with significant differences only at cutoff
titers of 10 and 20 levels.
Swine human-like H3N2 and seasonal H3N2 influenza
viruses. No differences were found between HI seroreactivity
detected in SWs and Cs against the swH3N2 virus, at each cutoff
value. SPRs for huH3N2 virus were significantly higher in Cs than
in SWs at all cutoff titers.
Pre- and Post-pandemic Peak Periods: Comparison of
Serological Results between and Within SWs and Cs
Taking into account the conventional 1 November 2009 cutoff
date (pre- and post- pandemic peak), seroprevalences to swH1N1
and H1N1pdm viruses were compared, as shown in Table 5,
Figures 1 and Figure 2. Binary logistic regression showed higher
SPRs in SWs in both pre- and post-pandemic period (Table 5), at
all cutoff levels with the exception of cutoff $40 for swH1N1 in
the post-pandemic period, where very low cell frequency was
observed.
Comparing pre- and post- pandemic peak HI results, no
significant difference in SPRs was found in SWs sera tested against
H1N1pdm (Figure 1B) and SwH1N1 (Figure 1A) viruses.
Conversely, H1N1pdm SPRs were significantly higher in Cs sera
collected during the post- pandemic peak period, at all cutoff titer
levels (Figure 2B); a significant increase in SPRs was also found to
SwH1N1 at cutoff $20 (Figure 2A).
The overall proportion of SWs with antibody levels $40 against
H1N1pdm was 31.7% (Table 4), ranging from 28.6% in the pre-
pandemic peak period to 38.5% in the post-pandemic peak one
(Table 5). In logistic regression models the seropositivity of SWs to
Table 1. Characteristics of the swine worker and control groups.
Variable Subcategory Study period
Pre-pandemic peak‘ Post-pandemic peak‘ Total
SWs, n (%) Cs, n (%) SWs, n (%) Cs, n (%) SWs, n (%) Cs, n (%)
84 (68.3) 234 (61.7) 39 (31.7) 145 (38.3) 123 (100) 379 (100)
Age #40 years{ 24 (28.6) 111 (47.4) 16 (41.0) 85 (58.6) 40 (32.5) 196 (51.7)
41–50 years 33 (39.3) 77 (32.9) 12 (30.8) 38 (26.2) 45 (36.6) 115 (30.3)
.50 years{ 27 (32.1) 46 (19.7) 11 (28.2) 22 (15.2) 38 (30.9) 68 (17.9)
Sex{ Male 79 (94.0) 161 (68.8) 38 (97.4) 129 (89.0) 117 (95.1) 290 (76.5)
Female 5 (6.0) 73 (31.2) 1 (2.6) 16 (11.0) 6 (4.9) 89 (23.5)
Seasonal Yes 16 (19.0) 61 (26.1) 7 (17.9) 27 (18.6) 23 (18.7) 88 (23.2)
vaccine* No 68 (81.0) 173 (73.9) 32 (82.1) 118 (81.4) 100 (81.3) 291 (76.8)
*Seasonal vaccine was defined as any previous vaccination against seasonal influenza.
{p,0.05. The calculated p-value is referred to total numbers of swine workers (SWs) and controls (Cs).
‘Pandemic peak cut-off date 1 November 2009.
doi:10.1371/journal.pone.0057576.t001
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swH1N1 (HI titers $20 and $40) was associated with antibody
levels $40 against H1N1pdm, supporting the existence of cross-
reactivity between these viruses; age did not appear to be an
explanatory variable.
Geometric mean titers (GMTs) of antibodies to H1N1pdm virus
detected in SWs in the pre-pandemic and post-pandemic peak
periods were 14.86 vs. 16.45, respectively; in the same periods,
GMTs of H1N1pdm antibodies in Cs were 5.93 vs. 9.22.
Discussion
Serosurveys represent an useful tool to highlight the zoonotic
risk posed by swine influenza, allowing a better quantification of
SIV associated human infections when compared to surveillance
systems based on virological diagnosis of influenza-like illness [10].
Seroprevalence studies provided indirect evidence of SIV trans-
mission to swine-exposed workers in North America [11–17],
Europe [18–20] and Thailand [21].
The Italian pig farming developed in the 1960s in the Po valley;
in 2007 the Italian pig population was more than 9 million heads,
Table 2. Swine and human influenza viruses: HI antigenic characterization of H1 strains.
HI titer of serum against:
Virus origin Virus strain
A/Sw/It/114347–1/06
(H1N2)*
A/Sw/It/125746/05
(H1N1)*
A/Brisbane/59/07
(H1N1)*
A/California/7/09
(H1N1)**
Swine A/Sw/It/114347-1/06, H1N2‘ 80 ,10 ,10 ,10
Swine A/Sw/It/125746/05, H1N1 ,10 1280 10 80
A/Sw/It/66732/2/06, H1N1‘ ,10 1280 ,10 320
A/Sw/It/87491/06, H1N1‘ ,10 1280 ,10 160
A/Sw/It/45894/2/07, H1N1‘ ,10 640 ,10 160
A/Sw/It/68030/07, H1N1‘ ,10 640 ,10 160
A/Sw/It/232868/07, H1N1‘ ,10 1280 ,10 320
A/Sw/It/207871/08, H1N1‘ ,10 640 ,10 160
A/Sw/It/44795/08, H1N1‘ ,10 640 ,10 160
Human A/Brisbane/59/07, H1N1 10 20 1280 ,10
A/California/7/09, H1N1 ,10 160 ,10 1280
HI, Haemagglutination inhibition.
*Chicken hyperimmune antiserum.
**Ferret post-infection antiserum.
Virus strains used to test swine workers’ and controls’ sera are underlined.
‘SIVs strains isolated from pigs, in the farms under study.
doi:10.1371/journal.pone.0057576.t002
Table 3. Swine and human influenza viruses: HI antigenic characterization of H3 strains.
HI titer of serum against:
Virus origin Virus strain A/Sw/It/79604/06 (H3N2)* A/Brisbane/10/07 (H3N2)*
Swine A/Sw/It/79604/06, H3N2 2560 ,10
A/Sw/It/32242/06, H3N2‘ 1280 ,10
A/Sw/It/20319/06, H3N2‘ 1280 ,10
A/Sw/It/186423/07, H3N2‘ 640 ,10
A/Sw/It/206453/07, H3N2‘ 1280 ,10
A/Sw/It/319388/07, H3N2‘ 1280 ,10
A/Sw/It/209720/08, H3N2‘ 1280 ,10
A/Sw/It/136775/08, H3N2‘ 1280 ,10
A/Sw/It/120014/08, H3N2‘ 1280 ,10
A/Sw/It/117304/08, H3N2‘ 640 ,10
A/Sw/It/235509/08, H3N2‘ 640 ,10
Human A/Uruguay/716/07, H3N2 ,10 2560
HI, Haemagglutination inhibition.
*Chicken hyperimmune antiserum.
Virus strains used to test swine workers’ and controls’ sera are underlined.
‘SIVs strains isolated from pigs, in the farms under study.
doi:10.1371/journal.pone.0057576.t003
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mainly concentrated in the four Northern regions of Lombardia,
Emilia-Romagna, Piemonte and Veneto [30].
The present observational cross-sectional study of occupational
medicine, conducted in the Lombardia Region between 2008 and
2010, was planned to assess the risk of occupational exposure to
swine influenza, by testing human sera against SIVs representative
of the Eurasian avian-like H1N1 and human-like H3N2 and
H1N2 lineages [22–23].
It should be noted that concurrent veterinary SIV monitoring
programs in the pig population [4] allowed us to: i) identify, in
a densely populated pig area, SIV infected farms; ii) choose, by
antigenic characterisation (Tables 2 and Table3), SIV strains to be
used in the present serosurvey; iii) test SWs sera against selected
SIV strains to which they were exposed.
Table 1 provides some demographic and individual character-
istics of worker groups exposed and unexposed to SIVs. Only
18.7% of SWs and 23.2% of Cs were vaccinated against seasonal
influenza (Table 1) showing vaccination coverages lower than
values recently reported in Luxembourg [19] and Germany [20].
Study results (ORs reported in Table 4 and Table 5) show that
SWs are at higher risk than Cs for swH1N1 virus infection, caused
by the prevalent SIV antigenic subtype, which is endemic in
Italian pig farms [23], thus showing much greater odds than did
Cs of being seropositive against both the swH1N1 and H1N1pdm
viruses (Table 4). Our results are consistent with previous serologic
studies conducted in Europe, showing that subjects occupationally
exposed to swine had more anti-swH1N1 antibodies than controls
[19–20]. Similar studies, in North America and Thailand, showed
antibody seroprevalences against classical swine H1N1 viruses
[11–16,21].
As detected by cross HI-test (Table 2) seroprevalence results
confirmed that antibody responses against swH1N1 and
H1N1pdm viruses correlated with each other, despite the wide
antigenic and genetic distance between the H1 haemagglutinin of
the European avian-like H1N1 SIV and H1N1pdm virus [29]. HI
antibodies showing ‘‘unexpected’’ cross-reactivities against
H1N1pdm strains, have also been detected in swine workers and
pigs infected and/or vaccinated, respectively, with European
avian-like H1N1 SIVs [19,31].
Notwithstanding the HA gene human origin of the swH1N2
virus used in this study, the antigenic characterization (Table 2)
showed very low cross-reaction of swH1N2 antiserum against
human H1N1 seasonal virus (HI titers of 10). Similarly, although
HA gene of swH3N2 derived from human influenza viruses, no
cross-reactivity was detected between antiserum raised against this
SIV strain and the seasonal H3N2 virus (Table 3). Characteriza-
tion results can be explained by the much slower evolution rate of
influenza A viruses circulating in pigs, when compared to that of
the human counterparts [29,31]. However, in the present
serosurvey comparable HI seroreactivities were detected at each
HI cutoff value (Table 4) in SWs and Cs against both swH1N2 and
swH3N2 viruses; these data can be explained with the lifetime
Table 4. HI antibody reactivity of SWs and Cs sera against swine and human influenza viruses during the whole study period (Italy,
2008–2010)1.
Virus Cutoff value SWs, N=123 Cs, N=379 Unadjusted OR Adjusted OR
‘
n (%) n (%) (95% CI) (95% CI)
swH1N1 $10 67 (54.5) 25 (6.6) 16.9 (9.9–29.0)*** 17.2 (2.3–0.2)***
$20 39 (31.7) 13 (3.4) 13.1 (6.7–25.6)*** 12.3 (6.3–25.0)***
$40 14 (11.4) 7 (1.8) 6.8 (2.7–17.3)*** 6.6 (2.5–17.4)***
huH1N1pdm $10 72 (58.5) 64 (16.9) 6.9 (4.4–10.9)*** 7.3 (4.6–12.6)***
$20 62 (50.4) 45 (11.9) 7.5 (4.7–12.1)*** 7.6 (4.7–12.4)***
$40 39 (31.7) 32 (8.4) 5.0 (3.0–8.5)*** 5.3 (3.1–9.2)***
swH1N2 $10 41 (33.3) 153 (40.4) 0.7 (0.5–1.1) 0.7 (0.5–1.1)
$20 30 (24.4) 93 (24.5) 1.0 (0.6–1.6) 1.0 (0.6–1.7)
$40 19 (15.4) 44 (11.6) 1.4 (0.8–2.5) 1.5 (0.8–2.8)
huH1N1 $10 58 (47.2) 228 (60.2) 0.6 (0.4–0.9)** 0.6 (0.4–0.9)**
$20 45 (36.6) 193 (50.9) 0.6 (0.4–0.8)** 0.6 (0.4–0.9)**
$40 35 (28.5) 150 (39.6) 0.8 (0.4 –1.4) nc
swH3N2 $10 63 (51.2) 210 (55.4) 0.8 (0.6–1.3) 0.8 (0.5–1.3)
$20 49 (39.8) 161 (42.5) 0.9 (0.6–1.4) 1 (0.6–1.4)
$40 34 (27.6) 110 (29.0) 0.9 (0.6–1.5) 0.9 (0.6–1.5)
huH3N2 $10 51 (41.5) 218 (57.5) 0.5 (0.3–0.8)** 0.8 (0.6–1.3)**
$20 43 (35.0) 188 (49.6) 0.5 (0.4–0.8)** 0.9 (0.6–1.4)**
$40 35 (28.5) 147 (38.8) 0.6 (0.4–0.1)* 1 (0.6–1.6)*
1Values are no. persons with antibodies.
‘Data adjusted by age in binary logistic regression.
HI, Haemagglutination inhibition.
SWs, swine workers; Cs, controls.
OR, odds ratio; CI, confidence interval; nc, not calculated.
swH1N1, A/Swine/Italy/44795/08; huH1N1pdm, A/California/7/09;
swH1N2, A/Swine/Italy/114347–1/06; huH1N1, A/Brisbane/59/07;
swH3N2, A/Swine/Italy/32242/06; huH3N2, A/Uruguay/716/07.
Statistically significant values: *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0057576.t004
Influenza Serosurvey in Italian Swine Workers
PLOS ONE | www.plosone.org 5 February 2013 | Volume 8 | Issue 2 | e57576
exposure of both study groups to human seasonal influenza
viruses, resulting in a broad heterosubtypic immunity [32] and
subsequent complexity to discriminate specific antibody responses
against swine and human viruses. Notably, as also described by
Lo´pez -Robles et al. in Northwestern Mexico [17], our study
showed lower percentages of seropositives for huH1N1 and
huH3N2 viruses in SWs compared to the Cs (Table 4).
The present occupational study is unique in that its time frame
included the complete periods of onset and global spread of the
H1N1 2009 influenza pandemic [26,33], giving us the opportunity
to compare the immune response in study groups (SWs and Cs)
before and after the pandemic peak.
SWs were at higher risk than Cs for swH1N1 infection in the
whole study period, in the pre- and in the post-pandemic periods.
Across the cutoff levels, ORs of having antibodies against swH1N1
were 6.6 to 17.2 greater for SWs than for Cs in the whole period,
17.4 to 22.2 in the pre-pandemic period and 2.3 to 13.6 in the
post-pandemic period. However, ORs decreased after the
pandemic peak (cutoff $10, 22.2 vs. 13.6; cutoff $20, 25.7 vs.
7.6; cutoff $40, 17.4 vs. 2.3) as a result of a significant increase of
cross-reactive antibody response in Cs, due to probable H1N1pdm
infections (Table 5 and Figure 2A). Consistent with the above
mentioned cross-reactivity (swine and pandemic H1N1 viruses),
the same trend is observed for H1N1pdm (cutoff $10, 16.7 vs. 3.1;
Figure 1. HI antibody reactivity against swH1N1 and H1N1pdm viruses in SWs (Italy, 2008–2010). Serum samples were collected from
swine workers (SWs) in the pre-pandemic peak (15 December 2008–1 November 2009) and post-pandemic peak (2 November 2009–3 October 2010)
periods and tested by haemagglutination inhibition (HI) assay. Individual HI results referred to the three cutoff levels ($10, $20 and$40) chosen for
the statistical analysis of data, and ranging from 10 (minimum level of detection) to 40 (protective antibody titer). No significant difference in
seroprevalence rate (SPR) was found in SWs sera tested by HI assay against swH1N1 (Figure 1A) and H1N1pdm (Figure 1B) viruses (viruses details and
SPRs are shown in Table 5).
doi:10.1371/journal.pone.0057576.g001
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cutoff $20, 14.5 vs. 4.1; cutoff $40, 8.1 vs. 3.7); post-pandemic
lower ORs values account for a significant increase of control
subjects with antibodies against H1N1pdm (Table 5 and
Figure 2B).
The opportunity to analyze the antibody results of sera collected
during the pandemic period, allowed us to postulate that anti-
swH1N1 antibodies have induced cross-reactive immunity in SWs
against the H1N1pdm virus. In fact, the significant increase of
H1N1pdm seroprevalences occurred in the post-pandemic peak
period in the Cs group (Table 5 and Figure 2B), compared to the
lack of significant differences observed in SWs (Table 5 and
Figure 1B), suggests the occurrence of cross-protective immunity to
H1N1pdm virus in Italian SWs, previously infected by
swH1N1viruses.
The overall proportion of SWs with antibody levels $40 against
H1N1pdm was 31.7% (Table 4), ranging from 28.6% in the pre-
pandemic peak period to 38.5% in the post-pandemic peak one
(Table 5). All the above values could have contributed to
protection against the H1N1pdm virus.
GMTs to H1N1pdm virus we detected in Cs in the pre-
pandemic and post-pandemic peak periods (5.93 vs. 9.22, re-
spectively) are in agreement with GMT values previously reported
in other European countries [34].
Our data of seroprevalence and risk analysis may have public
health impact, providing elements useful for the prevention and
control of influenza A viruses with pandemic potential. Such
actions may include both direct prophylaxis activities, designed to
prevent SIV infection in occupationally exposed workers, and
vaccination measures, aimed to counteract co-infections of SWs
Figure 2. HI antibody reactivity against swH1N1 and H1N1pdm viruses in Cs (Italy, 2008–2010). Serum samples were collected from
control subjects (Cs) in the pre-pandemic peak (15 December 2008–1 November 2009) and post-pandemic peak (2 November 2009–3 October 2010)
periods and tested by haemagglutination inhibition (HI) assay. Individual HI results referred to the three cutoff levels ($10, $20 and$40) chosen for
the statistical analysis of data, and ranging from 10 (minimum level of detection) to 40 (protective antibody titer). A significant increase in
seroprevalence rate (SPR) was found against swH1N1 at cutoff $20 (Figure 2A), whereas H1N1pdm SPRs (Figure 2B) were significantly higher in the
post-pandemic peak period, at all cutoff titer levels (viruses details and SPRs are shown in Table 5). SPR significant difference (p,0.05).
doi:10.1371/journal.pone.0057576.g002
Influenza Serosurvey in Italian Swine Workers
PLOS ONE | www.plosone.org 7 February 2013 | Volume 8 | Issue 2 | e57576
with influenza A viruses of human and animal origin, underlying
the possible emergence of new pandemic strains by reassortment
events [35–36]. Moreover, we found that only a limited number of
SWs were vaccinated against human influenza (Table 1), empha-
sising the importance of including swine workers in seasonal and
pandemic influenza prevention planning.
In addition, our findings enhance the understanding of cross-
reactivity immunity elicited by swine and human influenza virus
infections, recently analyzed in humans [37] and animal models
[31,38–39]. In the present study we postulated that prior infection
with swH1N1 virus can provide cross-protective humoral immu-
nity to H1N1pdm virus. However, it is important to consider that
pre-existing T cell-mediated heterologous immunity could also
have contributed to protect SWs against H1N1pdm virus infection
[40].
Since H1N1pdm pandemic became a matter of fact during the
survey period, the present study was not specifically designed to
test the presence of humoral immunity against H1N1pdm in
humans previously exposed to swH1N1 viruses; sampling
procedures were neither consequently tailored for this purposes,
nor balanced for temporal comparison between pre- and post-
pandemic peak periods. However despite all these limitations, to
our knowledge, this study is unique in documenting exposure of
SWs and control population to SIVs and human influenza viruses
at the onset and during the spread of the 2009 influenza
pandemic.
In summary, our findings provide new insights into the human
immunity to swine influenza viruses. We also confirm that swine
workers are at significant risk to become infected by SIVs, thus
underlying the crucial role of an integrated occupational medicine
and veterinary surveillance aimed to assess the health risk
represented by zoonotic viruses.
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